About Alpa Laboratories Limited
Data last updated: 06 January 2026
Alpa Laboratories Limited is a public limited company based in Indore, Madhya Pradesh, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 18 March 1988, the company has been in operation for over 38 years.
Registered with ROC Gwalior under CIN L85195MP1988PLC004446. Listed on BSE: 532878 and NSE: BE : ALPA.
Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹21.04 Cr. Formerly known as Alpa Laboratories Private Limited. It is led by directors including Pravin Chandra Shah and Pratibha Lunawat.
Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: 33/2 A.B. Road Pigdamber Rao, Indore, Madhya Pradesh, India – 453446.
As per the financials filed for FY 2025, the company reported a revenue of ₹135.8 Cr, a growth of 10% compared to the previous year.
The company has a workforce of approximately 367 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 2 brands - Alpa Labs, Alpa Labs. As per MCA filings, the company has open charges of ₹26 Cr and satisfied charges of ₹81.73 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alpalabs.in.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered Address33/2 A.B. Road Pigdamber Rao, Indore, Madhya Pradesh, India – 453446
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Alpa Laboratories Limited
Alpa Laboratories Limited has one previous CIN (Corporate Identification Number): U85195MP1988PLC004446. The current CIN is L85195MP1988PLC004446, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85195MP1988PLC004446 | Current |
| U85195MP1988PLC004446 | Previous |
Associated Brands with Alpa Laboratories Limited
Alpa Laboratories Limited operates two associated brands: Alpa Labs and Alpa Labs. These brands represent Alpa Laboratories Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Generic drugs manufacturer & exporter | alpalabs.com | |
| Alpa Labs is engaged in manufacturing pharmaceutical dosage forms. | alpalabs.in |
Business Activity of Alpa Laboratories Limited
Alpa Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Alpa Laboratories Limited
Alpa Laboratories Limited is audited by CH Padliya and Co. (ICAI peer reviewed, certificate valid till 2026-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| CH Padliya and Co. (ICAI peer reviewed, certificate valid till 2026-07-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Alpa Laboratories Limited
Alpa Laboratories Limited is currently managed by 12 directors, with 23 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Pravin Chandra Shah
Also directs:
Alpa Laboratories Limited, Norfolk Mercantile Private Limited
|
Whole-Time Director | 01 Mar 2009 | 17 Years 4 Months | Current |
|
Pratibha Lunawat
Also directs:
Alpa Laboratories Limited
|
Director | 28 Aug 2023 | 2 Years 10 Months | Current |
|
Sunil Kumar Valecha
Also directs:
Alpa Laboratories Limited
|
Director | 28 Aug 2023 | 2 Years 10 Months | Current |
|
Vitthal Kothana
Also directs:
Alpa Laboratories Limited
|
Director | 13 Aug 2022 | 3 Years 10 Months | Current |
|
Bakulesh Shah
Also directs:
Alpa Laboratories Limited
|
Cfo | 29 May 2014 | 12 Years 1 Months | Current |
|
Mahendra Singh Chawla
Also directs:
Alpa Laboratories Limited, Norfolk Mercantile Private Limited
|
Whole-Time Director | 18 Mar 1988 | 38 Years 3 Months | Current |
Financials of Alpa Laboratories Limited FY 2026 filings available
Alpa Laboratories Limited reported revenue of ₹105.81 Cr (down 5.91% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue from Operations | ₹105.81 Cr | ₹112.45 Cr | ₹108.74 Cr | ₹92.44 Cr | ₹97.55 Cr | ₹85.97 Cr |
| Other Income | ₹15.76 Cr | ₹23.35 Cr | ₹14.89 Cr | ₹9.93 Cr | ₹4.4 Cr | ₹2.91 Cr |
| Total Income | ₹121.57 Cr | ₹135.8 Cr | ₹123.63 Cr | ₹102.37 Cr | ₹101.95 Cr | ₹88.88 Cr |
| Cost of Materials Consumed | ₹63.25 Cr | ₹70.72 Cr | ₹62.88 Cr | ₹54.67 Cr | ₹54.23 Cr | ₹49.48 Cr |
| Purchases of Stock-in-Trade | ₹16.4 Lakh | ₹93.11 Lakh | ₹5.8 Cr | ₹1.22 Cr | ₹6.4 Cr | ₹1.94 Cr |
| Changes in Inventories | ₹2.94 Cr | -₹1.45 Cr | -₹64.12 Lakh | ₹1.27 Cr | -₹1.15 Cr | -₹42.41 Lakh |
| Employee Benefit Expense | ₹15.81 Cr | ₹14.39 Cr | ₹13.29 Cr | ₹12.17 Cr | ₹11.75 Cr | ₹11.82 Cr |
| Finance Costs | ₹25.8 Lakh | ₹23.18 Lakh | ₹35.92 Lakh | ₹22.34 Lakh | ₹7.79 Lakh | ₹19.62 Lakh |
| Depreciation & Amortisation | ₹2.09 Cr | ₹2.2 Cr | ₹1.95 Cr | ₹1.33 Cr | ₹1.23 Cr | ₹3.16 Cr |
| Other Expenses | ₹20.35 Cr | ₹23.12 Cr | ₹19.31 Cr | ₹15.55 Cr | ₹18.65 Cr | ₹19.79 Cr |
| Total Expenses | ₹104.87 Cr | ₹110.13 Cr | ₹102.95 Cr | ₹86.43 Cr | ₹91.17 Cr | ₹85.97 Cr |
| Profit Before Exceptional Items & Tax | ₹16.7 Cr | ₹25.67 Cr | ₹20.68 Cr | ₹15.94 Cr | ₹10.78 Cr | ₹2.91 Cr |
| Exceptional Items | -₹88.39 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹15.81 Cr | ₹25.67 Cr | ₹20.68 Cr | ₹15.94 Cr | ₹10.78 Cr | ₹2.91 Cr |
| Total Tax Expense | ₹1.69 Cr | ₹6.16 Cr | ₹3.91 Cr | ₹3.31 Cr | ₹3.54 Cr | ₹1.05 Cr |
| Net Profit | ₹14.13 Cr | ₹19.5 Cr | ₹16.78 Cr | ₹12.63 Cr | ₹7.24 Cr | ₹1.85 Cr |
| attributable to Owners | - | ₹0 | - | ₹0 | ₹0 | - |
| attributable to NCI | - | ₹0 | - | ₹0 | ₹0 | - |
| Other Comprehensive Income | ₹0 | ₹14.96 Lakh | ₹8.16 Lakh | -₹20.98 Lakh | ₹2.17 Lakh | ₹2.49 Lakh |
| Total Comprehensive Income | ₹14.13 Cr | ₹19.65 Cr | ₹16.86 Cr | ₹12.42 Cr | ₹7.27 Cr | ₹1.88 Cr |
| EBITDA (computed) | ₹19.05 Cr | ₹28.1 Cr | ₹23 Cr | ₹17.49 Cr | ₹12.09 Cr | ₹6.27 Cr |
| Basic EPS | ₹6.71 | ₹9.34 | ₹8.01 | ₹5.90 | ₹3.45 | ₹0.89 |
| Diluted EPS | ₹0.00 | ₹9.34 | ₹8.01 | ₹5.90 | ₹3.45 | ₹0.89 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹242.14 Cr | ₹222.59 Cr | ₹182.62 Cr | ₹167.45 Cr |
| Non-current Assets | ₹31.25 Cr | ₹31.41 Cr | ₹21.39 Cr | ₹15.36 Cr |
| Current Assets | ₹210.9 Cr | ₹191.18 Cr | ₹161.23 Cr | ₹152.1 Cr |
| Property, Plant & Equipment | ₹20.12 Cr | ₹20.6 Cr | ₹11.41 Cr | ₹6.96 Cr |
| Inventories | ₹13.33 Cr | ₹17.64 Cr | ₹13.67 Cr | ₹12.64 Cr |
| Trade Receivables | ₹40.83 Cr | ₹46.83 Cr | ₹41.4 Cr | ₹46.73 Cr |
| Cash & Equivalents | ₹63.72 Lakh | ₹2.65 Lakh | ₹6.03 Lakh | ₹8.81 Cr |
| Equity (Net Worth) | ₹186.28 Cr | ₹171.43 Cr | ₹151.91 Cr | ₹134.58 Cr |
| Equity Share Capital | ₹21.04 Cr | ₹21.04 Cr | ₹21.04 Cr | ₹21.04 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹2.3 Cr |
| Borrowings (Current) | ₹2.51 Cr | ₹0 | ₹5.25 Cr | ₹0 |
| Total Debt (computed) | ₹2.51 Cr | ₹0 | ₹5.25 Cr | ₹2.3 Cr |
| Current Liabilities | ₹52.53 Cr | ₹46.67 Cr | ₹28.32 Cr | ₹30.57 Cr |
| Total Liabilities | ₹55.86 Cr | ₹51.16 Cr | ₹30.71 Cr | ₹32.87 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | ₹10.66 Cr | ₹7.06 Cr | ₹3.65 Cr | -₹4.85 Cr |
| Investing Cash Flow | -₹12.27 Cr | -₹1.1 Cr | -₹13.34 Cr | ₹1.17 Cr |
| Financing Cash Flow | ₹2.22 Cr | -₹5.48 Cr | ₹2.58 Cr | -₹3.48 Cr |
| Capital Expenditure | ₹3.95 Cr | ₹11.38 Cr | ₹6.39 Cr | ₹1.13 Cr |
| Free Cash Flow (computed) | ₹6.71 Cr | -₹4.32 Cr | -₹2.74 Cr | -₹5.97 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹61.65 Lakh | ₹47.78 Lakh | -₹7.1 Cr | -₹7.15 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹31.4 Cr | ₹29.05 Cr | ₹26.26 Cr | ₹19.11 Cr | ₹39.92 Cr | ₹26.15 Cr | ₹24.94 Cr | ₹21.44 Cr | ₹23.61 Cr | ₹27.31 Cr | ₹32.39 Cr | ₹25.43 Cr |
| Other Income | -₹15.86 Lakh | ₹91.1 Lakh | ₹3.06 Cr | ₹11.94 Cr | ₹2.48 Cr | ₹8.8 Cr | ₹6.91 Cr | ₹5.16 Cr | ₹3.97 Cr | ₹3.53 Cr | ₹2.95 Cr | ₹4.44 Cr |
| Total Income | ₹31.24 Cr | ₹29.96 Cr | ₹29.32 Cr | ₹31.06 Cr | ₹42.4 Cr | ₹34.95 Cr | ₹31.85 Cr | ₹26.6 Cr | ₹27.57 Cr | ₹30.84 Cr | ₹35.35 Cr | ₹29.87 Cr |
| Cost of Materials Consumed | ₹16.6 Cr | ₹18.09 Cr | ₹16.62 Cr | ₹11.94 Cr | ₹31.66 Cr | ₹12.74 Cr | ₹12.1 Cr | ₹14.22 Cr | ₹9.29 Cr | ₹15.42 Cr | ₹21.01 Cr | ₹17.16 Cr |
| Purchases of Stock-in-Trade | ₹13.18 Lakh | ₹2.07 Lakh | ₹1.16 Lakh | ₹0 | ₹2.39 Lakh | ₹48.42 Lakh | ₹23.18 Lakh | ₹19.12 Lakh | ₹2.33 Cr | ₹79.5 Lakh | ₹1.5 Cr | ₹1.17 Cr |
| Changes in Inventories | -₹64.93 Lakh | ₹1.28 Cr | ₹3.26 Cr | -₹95.16 Lakh | -₹4.02 Cr | ₹1.28 Cr | ₹1.95 Cr | -₹66.71 Lakh | -₹1.08 Cr | ₹25.85 Lakh | -₹1.79 Cr | ₹1.97 Cr |
| Employee Benefit Expense | ₹5.04 Cr | ₹3.72 Cr | ₹3.62 Cr | ₹3.43 Cr | ₹4.33 Cr | ₹3.36 Cr | ₹3.38 Cr | ₹3.32 Cr | ₹3.87 Cr | ₹3.2 Cr | ₹3.25 Cr | ₹2.97 Cr |
| Finance Costs | ₹14.87 Lakh | ₹2.74 Lakh | ₹3.43 Lakh | ₹4.75 Lakh | ₹1.57 Lakh | ₹9.03 Lakh | ₹5.08 Lakh | ₹5.17 Lakh | ₹29.44 Lakh | ₹2.41 Lakh | ₹2.37 Lakh | ₹1.7 Lakh |
| Depreciation & Amortisation | ₹22.05 Lakh | ₹64.65 Lakh | ₹67.15 Lakh | ₹55.33 Lakh | ₹58.13 Lakh | ₹55.06 Lakh | ₹52.78 Lakh | ₹54.28 Lakh | ₹52.47 Lakh | ₹66.18 Lakh | ₹49.29 Lakh | ₹27.55 Lakh |
| Other Expenses | ₹6.67 Cr | ₹4.42 Cr | ₹4.99 Cr | ₹4.27 Cr | ₹7.73 Cr | ₹7.54 Cr | ₹3.95 Cr | ₹3.85 Cr | ₹5.68 Cr | ₹5.21 Cr | ₹5.07 Cr | ₹3.3 Cr |
| Total Expenses | ₹28.17 Cr | ₹28.21 Cr | ₹29.2 Cr | ₹19.29 Cr | ₹40.32 Cr | ₹26.05 Cr | ₹22.2 Cr | ₹21.51 Cr | ₹20.92 Cr | ₹25.56 Cr | ₹29.56 Cr | ₹26.86 Cr |
| Profit Before Exceptional Items & Tax | ₹3.07 Cr | ₹1.75 Cr | ₹11.24 Lakh | ₹11.77 Cr | ₹2.08 Cr | ₹8.9 Cr | ₹9.65 Cr | ₹5.1 Cr | ₹6.65 Cr | ₹5.28 Cr | ₹5.79 Cr | ₹3 Cr |
| Exceptional Items | -₹88.39 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1.78 Lakh | ₹1.78 Lakh | ₹0 | ₹2.84 Lakh |
| Profit Before Tax | ₹2.19 Cr | ₹1.75 Cr | ₹11.24 Lakh | ₹11.77 Cr | ₹2.08 Cr | ₹8.9 Cr | ₹9.65 Cr | ₹5.1 Cr | ₹6.67 Cr | ₹5.3 Cr | ₹5.79 Cr | ₹3.03 Cr |
| Total Tax Expense | ₹1.69 Cr | -₹15.59 Lakh | ₹0 | ₹0 | ₹4.2 Cr | ₹20,000 | ₹1.96 Cr | ₹0 | ₹3.12 Cr | ₹78.74 Lakh | ₹0 | ₹0 |
| Net Profit | ₹49.87 Lakh | ₹1.9 Cr | ₹11.24 Lakh | ₹11.77 Cr | -₹2.12 Cr | ₹8.9 Cr | ₹7.69 Cr | ₹5.1 Cr | ₹3.55 Cr | ₹4.51 Cr | ₹5.79 Cr | ₹3.03 Cr |
| attributable to Owners | - | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 |
| attributable to NCI | - | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹13.06 Lakh | -₹18,000 | ₹42,000 | -₹26,000 | ₹3.58 Lakh | ₹5.72 Lakh | ₹4.58 Lakh | ₹0 |
| Total Comprehensive Income | ₹49.87 Lakh | ₹1.9 Cr | ₹11.24 Lakh | ₹11.77 Cr | -₹1.99 Cr | ₹8.9 Cr | ₹7.69 Cr | ₹5.09 Cr | ₹3.59 Cr | ₹4.57 Cr | ₹5.84 Cr | ₹3.03 Cr |
| EBITDA (computed) | ₹3.44 Cr | ₹2.42 Cr | ₹81.82 Lakh | ₹12.37 Cr | ₹2.67 Cr | ₹9.54 Cr | ₹10.23 Cr | ₹5.69 Cr | ₹7.47 Cr | ₹5.96 Cr | ₹6.31 Cr | ₹3.3 Cr |
| Basic EPS | ₹0.24 | ₹0.90 | ₹0.05 | ₹5.59 | ₹-0.95 | ₹4.23 | ₹3.66 | ₹2.42 | ₹1.71 | ₹2.17 | ₹2.75 | ₹1.44 |
| Diluted EPS | ₹0.00 | ₹0.90 | ₹0.05 | ₹5.59 | ₹-0.95 | ₹4.23 | ₹3.66 | ₹2.42 | ₹1.71 | ₹2.17 | ₹2.75 | ₹1.44 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue from Operations | ₹105.81 Cr | ₹111.64 Cr | ₹108.74 Cr | ₹92.44 Cr | ₹97.55 Cr | ₹85.97 Cr |
| Other Income | ₹15.72 Cr | ₹24.11 Cr | ₹14.87 Cr | ₹9.93 Cr | ₹4.41 Cr | ₹2.97 Cr |
| Total Income | ₹121.53 Cr | ₹135.76 Cr | ₹123.61 Cr | ₹102.36 Cr | ₹101.96 Cr | ₹88.94 Cr |
| Cost of Materials Consumed | ₹63.25 Cr | ₹70.72 Cr | ₹62.88 Cr | ₹54.67 Cr | ₹54.23 Cr | ₹49.48 Cr |
| Purchases of Stock-in-Trade | ₹16.41 Lakh | ₹93.11 Lakh | ₹5.8 Cr | ₹1.22 Cr | ₹6.39 Cr | ₹1.94 Cr |
| Changes in Inventories | ₹2.94 Cr | -₹1.45 Cr | -₹64.12 Lakh | ₹1.27 Cr | -₹1.15 Cr | -₹42.41 Lakh |
| Employee Benefit Expense | ₹15.8 Cr | ₹14.37 Cr | ₹13.26 Cr | ₹12.17 Cr | ₹11.75 Cr | ₹11.82 Cr |
| Finance Costs | ₹29.22 Lakh | ₹26.63 Lakh | ₹38.93 Lakh | ₹22.34 Lakh | ₹9.82 Lakh | ₹19.94 Lakh |
| Depreciation & Amortisation | ₹2.09 Cr | ₹2.2 Cr | ₹1.95 Cr | ₹1.33 Cr | ₹1.23 Cr | ₹1.14 Cr |
| Other Expenses | ₹20.35 Cr | ₹22.88 Cr | ₹19.3 Cr | ₹15.54 Cr | ₹18.63 Cr | ₹19.7 Cr |
| Total Expenses | ₹104.89 Cr | ₹109.92 Cr | ₹102.94 Cr | ₹86.43 Cr | ₹91.17 Cr | ₹83.86 Cr |
| Profit Before Exceptional Items & Tax | ₹16.64 Cr | ₹25.84 Cr | ₹20.67 Cr | ₹15.93 Cr | ₹10.79 Cr | ₹5.08 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹16.64 Cr | ₹25.84 Cr | ₹20.67 Cr | ₹15.93 Cr | ₹10.79 Cr | ₹5.08 Cr |
| Total Tax Expense | ₹1.69 Cr | ₹6.16 Cr | ₹3.9 Cr | ₹3.31 Cr | ₹3.53 Cr | ₹99.92 Lakh |
| Net Profit | ₹14.95 Cr | ₹19.68 Cr | ₹16.78 Cr | ₹12.63 Cr | ₹7.26 Cr | ₹4.08 Cr |
| Other Comprehensive Income | -₹88.4 Lakh | ₹14.96 Lakh | ₹8.16 Lakh | -₹20.98 Lakh | ₹2.17 Lakh | ₹2.49 Lakh |
| Total Comprehensive Income | ₹14.07 Cr | ₹19.83 Cr | ₹16.86 Cr | ₹12.42 Cr | ₹7.29 Cr | ₹4.1 Cr |
| EBITDA (computed) | ₹19.02 Cr | ₹28.31 Cr | ₹23.02 Cr | ₹17.48 Cr | ₹12.12 Cr | ₹6.42 Cr |
| Basic EPS | ₹6.69 | ₹9.42 | ₹8.01 | ₹5.90 | ₹3.46 | ₹1.95 |
| Diluted EPS | ₹0.00 | ₹9.42 | ₹8.01 | ₹5.90 | ₹3.46 | ₹1.95 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹251.38 Cr | ₹232.95 Cr | ₹192.67 Cr | ₹177.69 Cr |
| Non-current Assets | ₹42.62 Cr | ₹42.8 Cr | ₹32.65 Cr | ₹26.5 Cr |
| Current Assets | ₹208.75 Cr | ₹190.15 Cr | ₹160.02 Cr | ₹151.18 Cr |
| Property, Plant & Equipment | ₹20.12 Cr | ₹20.6 Cr | ₹11.41 Cr | ₹6.96 Cr |
| Inventories | ₹13.33 Cr | ₹17.64 Cr | ₹13.67 Cr | ₹12.64 Cr |
| Trade Receivables | ₹40.83 Cr | ₹46.83 Cr | ₹41.4 Cr | ₹46.73 Cr |
| Cash & Equivalents | ₹1.21 Cr | ₹2.59 Lakh | ₹4.81 Lakh | ₹8.79 Cr |
| Equity (Net Worth) | ₹196.58 Cr | ₹181.8 Cr | ₹161.97 Cr | ₹144.53 Cr |
| Equity Share Capital | ₹21.04 Cr | ₹21.04 Cr | ₹21.04 Cr | ₹21.04 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹2.3 Cr |
| Borrowings (Current) | ₹1.51 Cr | ₹0 | ₹5.25 Cr | ₹29 Lakh |
| Total Debt (computed) | ₹1.51 Cr | ₹0 | ₹5.25 Cr | ₹2.59 Cr |
| Current Liabilities | ₹51.46 Cr | ₹46.65 Cr | ₹28.31 Cr | ₹30.85 Cr |
| Total Liabilities | ₹54.8 Cr | ₹51.15 Cr | ₹30.7 Cr | ₹33.16 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | ₹11.48 Cr | ₹18.39 Cr | ₹3.7 Cr | -₹4.85 Cr |
| Investing Cash Flow | -₹11.58 Cr | -₹12.49 Cr | -₹13.45 Cr | ₹1.17 Cr |
| Financing Cash Flow | -₹1.16 Cr | -₹5.51 Cr | ₹2.26 Cr | -₹3.48 Cr |
| Capital Expenditure | ₹3.95 Cr | ₹11.38 Cr | ₹6.39 Cr | ₹1.13 Cr |
| Free Cash Flow (computed) | ₹7.53 Cr | ₹7.01 Cr | -₹2.69 Cr | -₹5.98 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹1.26 Cr | ₹39.15 Lakh | -₹7.49 Cr | -₹7.16 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹31.4 Cr | ₹29.67 Cr | ₹25.63 Cr | ₹19.11 Cr | ₹39.11 Cr | ₹26.15 Cr | ₹24.94 Cr | ₹21.44 Cr | ₹23.61 Cr | ₹27.31 Cr | ₹32.39 Cr | ₹25.43 Cr |
| Other Income | -₹18.28 Lakh | ₹26.05 Lakh | ₹3.69 Cr | ₹11.96 Cr | ₹3.24 Cr | ₹8.8 Cr | ₹6.91 Cr | ₹5.16 Cr | ₹3.95 Cr | ₹3.53 Cr | ₹2.95 Cr | ₹4.44 Cr |
| Total Income | ₹31.21 Cr | ₹29.93 Cr | ₹29.32 Cr | ₹31.07 Cr | ₹42.35 Cr | ₹34.95 Cr | ₹31.85 Cr | ₹26.6 Cr | ₹27.56 Cr | ₹30.84 Cr | ₹35.35 Cr | ₹29.87 Cr |
| Cost of Materials Consumed | ₹16.6 Cr | ₹18.16 Cr | ₹16.55 Cr | ₹11.94 Cr | ₹31.66 Cr | ₹12.74 Cr | ₹12.1 Cr | ₹14.22 Cr | ₹9.29 Cr | ₹15.42 Cr | ₹21.01 Cr | ₹17.16 Cr |
| Purchases of Stock-in-Trade | ₹13.18 Lakh | ₹2.07 Lakh | ₹1.16 Lakh | ₹0 | ₹2.39 Lakh | ₹48.42 Lakh | ₹23.18 Lakh | ₹19.12 Lakh | ₹2.33 Cr | ₹79.5 Lakh | ₹1.5 Cr | ₹1.17 Cr |
| Changes in Inventories | -₹64.94 Lakh | ₹1.28 Cr | ₹3.26 Cr | -₹95.16 Lakh | -₹4.02 Cr | ₹1.28 Cr | ₹1.95 Cr | -₹66.71 Lakh | -₹1.08 Cr | ₹25.85 Lakh | -₹1.79 Cr | ₹1.97 Cr |
| Employee Benefit Expense | ₹5.03 Cr | ₹3.72 Cr | ₹3.62 Cr | ₹3.43 Cr | ₹4.31 Cr | ₹3.36 Cr | ₹3.38 Cr | ₹3.31 Cr | ₹3.87 Cr | ₹3.17 Cr | ₹3.25 Cr | ₹2.97 Cr |
| Finance Costs | ₹16.21 Lakh | ₹3.14 Lakh | ₹4.61 Lakh | ₹5.26 Lakh | ₹5.02 Lakh | ₹10.11 Lakh | ₹6.16 Lakh | ₹5.34 Lakh | ₹30.39 Lakh | ₹3.2 Lakh | ₹3.64 Lakh | ₹1.7 Lakh |
| Depreciation & Amortisation | ₹22.05 Lakh | ₹64.65 Lakh | ₹67.15 Lakh | ₹55.33 Lakh | ₹58.13 Lakh | ₹55.06 Lakh | ₹52.78 Lakh | ₹54.28 Lakh | ₹52.47 Lakh | ₹66.18 Lakh | ₹49.29 Lakh | ₹27.55 Lakh |
| Other Expenses | ₹6.67 Cr | ₹4.35 Cr | ₹5.06 Cr | ₹4.27 Cr | ₹7.5 Cr | ₹7.54 Cr | ₹4 Cr | ₹3.85 Cr | ₹5.68 Cr | ₹5.2 Cr | ₹5.11 Cr | ₹3.31 Cr |
| Total Expenses | ₹28.17 Cr | ₹28.21 Cr | ₹29.22 Cr | ₹19.29 Cr | ₹40.1 Cr | ₹26.06 Cr | ₹22.26 Cr | ₹21.5 Cr | ₹20.92 Cr | ₹25.54 Cr | ₹29.61 Cr | ₹26.87 Cr |
| Profit Before Exceptional Items & Tax | ₹3.04 Cr | ₹1.72 Cr | ₹10.12 Lakh | ₹11.78 Cr | ₹2.25 Cr | ₹8.89 Cr | ₹9.59 Cr | ₹5.11 Cr | ₹6.64 Cr | ₹5.3 Cr | ₹5.74 Cr | ₹3 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1.82 Lakh | ₹1.78 Lakh | ₹1.78 Lakh | ₹0 | ₹2.84 Lakh |
| Profit Before Tax | ₹3.04 Cr | ₹1.72 Cr | ₹10.12 Lakh | ₹11.78 Cr | ₹2.25 Cr | ₹8.89 Cr | ₹9.59 Cr | ₹5.12 Cr | ₹6.66 Cr | ₹5.32 Cr | ₹5.74 Cr | ₹3.03 Cr |
| Total Tax Expense | ₹1.69 Cr | -₹15.59 Lakh | ₹0 | ₹0 | ₹4.2 Cr | ₹0 | ₹1.96 Cr | ₹0 | ₹3.11 Cr | ₹78.74 Lakh | ₹0 | ₹0 |
| Net Profit | ₹1.36 Cr | ₹1.87 Cr | ₹10.12 Lakh | ₹11.78 Cr | -₹1.95 Cr | ₹8.89 Cr | ₹7.63 Cr | ₹5.12 Cr | ₹3.55 Cr | ₹4.53 Cr | ₹5.74 Cr | ₹3.03 Cr |
| Other Comprehensive Income | -₹88.4 Lakh | ₹0 | ₹0 | ₹0 | ₹13.06 Lakh | ₹1.9 Lakh | ₹0 | ₹0 | ₹3.58 Lakh | ₹0 | ₹4.58 Lakh | ₹0 |
| Total Comprehensive Income | ₹47.3 Lakh | ₹1.87 Cr | ₹10.12 Lakh | ₹11.78 Cr | -₹1.82 Cr | ₹8.91 Cr | ₹7.63 Cr | ₹5.12 Cr | ₹3.58 Cr | ₹4.53 Cr | ₹5.78 Cr | ₹3.03 Cr |
| EBITDA (computed) | ₹3.43 Cr | ₹2.4 Cr | ₹81.88 Lakh | ₹12.38 Cr | ₹2.88 Cr | ₹9.54 Cr | ₹10.18 Cr | ₹5.7 Cr | ₹7.47 Cr | ₹5.99 Cr | ₹6.27 Cr | ₹3.29 Cr |
| Basic EPS | ₹0.64 | ₹0.89 | ₹0.05 | ₹5.60 | ₹-0.86 | ₹4.24 | ₹3.63 | ₹2.44 | ₹1.70 | ₹2.15 | ₹2.75 | ₹1.44 |
| Diluted EPS | ₹0.00 | ₹0.89 | ₹0.05 | ₹5.60 | ₹-0.86 | ₹4.24 | ₹3.63 | ₹2.44 | ₹1.70 | ₹2.15 | ₹2.75 | ₹1.44 |
Shareholding Pattern of Alpa Laboratories Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 57.19%, foreign institutional investors hold 0.38%, retail and other public shareholders hold 42.43% of Alpa Laboratories Limited. The company had 17,900 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 57.19% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% |
| Public | 42.81% | 42.71% | 42.71% | 42.71% | 42.71% | 42.71% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 57.19% | 57.29% | 57.29% | 57.29% | 57.29% | 56.66% | 56.66% | 56.66% | 54.61% | 54.61% | 54.61% |
| Public | 42.81% | 42.71% | 42.71% | 42.71% | 42.71% | 43.34% | 43.34% | 43.34% | 45.39% | 45.39% | 45.39% |
| Promoter change (YoY, %pts) | -0.10 | +0.00 | +0.00 | +0.00 | +0.63 | +0.00 | +0.00 | +2.05 | +0.00 | +0.00 | - |
Board & Governance of Alpa Laboratories Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Alpa Laboratories Limited has 10 directors - 5 independent and 5 executive. The board is chaired by MAHENDRA SINGH CHAWLA.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| MAHENDRA SINGH CHAWLA | Executive Director · Chairperson | 1988-03-18 | 1 |
| PARESH CHAWLA | Executive Director · MD | 2016-05-28 | 1 |
| PRAVIN CHANDRA SHAH | Executive Director | 2009-03-01 | 1 |
| JYOTI JAIN | Non-Executive - Independent Director | 2016-07-20 | 1 |
| VITTHAL KOTHANA | Executive Director | 2022-08-13 | 1 |
| SHITUL SHAH | Executive Director | 2023-08-14 | 1 |
| PRATIBHA LUNAWAT | Non-Executive - Independent Director | 2023-08-28 | 1 |
| SANKET BAHETI | Non-Executive - Independent Director | 2023-08-28 | 1 |
| SUNIL KUMAR VALECHA | Non-Executive - Independent Director | 2023-08-28 | 1 |
| PRATIK SHAH | Non-Executive - Independent Director | 2024-08-31 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | SUNIL KUMAR VALECHA (Chairperson), MAHENDRA SINGH CHAWLA, PRATIBHA LUNAWAT |
| Nomination and remuneration committee | SANKET BAHETI (Chairperson), JYOTI JAIN, SUNIL KUMAR VALECHA |
| Stakeholders Relationship Committee | SUNIL KUMAR VALECHA (Chairperson), MAHENDRA SINGH CHAWLA, JYOTI JAIN |
| Corporate Social Responsibility Committee | PRAVIN CHANDRA SHAH (Chairperson), SUNIL KUMAR VALECHA, PRATIBHA LUNAWAT |
Group Structure of Alpa Laboratories Limited
Alpa Laboratories Limited has 1 subsidiary company. This group structure data is as of FY 2024. The corporate group structure reflects Alpa Laboratories Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Norfolk Mercantile Private Limited | U74120MH2014PTC252923 | - |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Alpa Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jul 2025 | Hdfc Bank Limited | ₹7 Cr | Open |
| 06 Jan 2024 | Hdfc Bank Limited | ₹5 Cr | Open |
| 06 Dec 2017 | Others | ₹14 Cr | Open |
| 24 Apr 2019 | Yes Bank Limited | ₹10 Cr | Satisfied |
| 01 Sep 2017 | Hdfc Bank Limited | ₹37 Lakh | Satisfied |
Total charge records: 13 View all charges
Employees and EPFO Compliance at Alpa Laboratories Limited
Alpa Laboratories Limited has a workforce of 367 employees as of Apr 09, 2024.
Employee Count & EPFO Data of Alpa Laboratories Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Alpa Laboratories Limited
GSTIN & GST Filing Data of Alpa Laboratories Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Alpa Laboratories Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Alpa Laboratories Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Alpa Laboratories Limited
MSME Payment Delays by Alpa Laboratories Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Alpa Laboratories Limited
Subsidiaries & Group Companies of Alpa Laboratories Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Alpa Laboratories Limited with ownership details.
MCA Filings & Documents of Alpa Laboratories Limited
MCA Filings & Documents of Alpa Laboratories Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Alpa Laboratories Limited
Recent News on Alpa Laboratories Limited
Frequently Asked Questions about Alpa Laboratories Limited
Alpa Laboratories Limited is an active public limited company in the pharma sector based in Indore, Madhya Pradesh, India. It was incorporated on 18 March 1988 (38+ years old) and is registered under CIN L85195MP1988PLC004446. Listed on BSE: 532878 and NSE: BE : ALPA. The company has 367 employees.
Alpa Laboratories Limited reported revenue of ₹135.8 Cr for FY 2025 (up 10.00% YoY).
The current directors of Alpa Laboratories Limited are:
The primary industry of Alpa Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Alpa Laboratories Limited is listed on both BSE (code: 532878) and NSE (symbol: BE : ALPA).
Alpa Laboratories Limited can be reached at the registered office: 332 A.B. Road Pigdamber Rao, Indore, Madhya Pradesh, India – 453446, or through the website alpalabs.in.